Cargando…
Intravoxel incoherent motion model–based analysis of diffusion-weighted magnetic resonance imaging with 3 b-values for response assessment in locoregional therapy of hepatocellular carcinoma
PURPOSE: The aim of this study was to evaluate an intravoxel incoherent motion (IVIM) model–based analysis of diffusion-weighted imaging (DWI) for assessing the response of hepatocellular carcinoma (HCC) to locoregional therapy. PATIENTS AND METHODS: Respiratory-gated DWI (b=0, 50, and 800 s/mm(2))...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5079699/ https://www.ncbi.nlm.nih.gov/pubmed/27799790 http://dx.doi.org/10.2147/OTT.S113909 |
_version_ | 1782462586909884416 |
---|---|
author | Mürtz, Petra Penner, Arndt-Hendrik Pfeiffer, Anne-Kristina Sprinkart, Alois M Pieper, Claus C König, Roy Block, Wolfgang Schild, Hans H Willinek, Winfried A Kukuk, Guido M |
author_facet | Mürtz, Petra Penner, Arndt-Hendrik Pfeiffer, Anne-Kristina Sprinkart, Alois M Pieper, Claus C König, Roy Block, Wolfgang Schild, Hans H Willinek, Winfried A Kukuk, Guido M |
author_sort | Mürtz, Petra |
collection | PubMed |
description | PURPOSE: The aim of this study was to evaluate an intravoxel incoherent motion (IVIM) model–based analysis of diffusion-weighted imaging (DWI) for assessing the response of hepatocellular carcinoma (HCC) to locoregional therapy. PATIENTS AND METHODS: Respiratory-gated DWI (b=0, 50, and 800 s/mm(2)) was retrospectively analyzed in 25 patients who underwent magnetic resonance imaging at 1.5 T before and 6 weeks following the first cycle of transarterial chemoembolization therapy, transarterial ethanol-lipiodol embolization therapy, and transarterial radioembolization therapy. In addition to the determination of apparent diffusion coefficient, ADC(0,800), an estimation of the diffusion coefficient, D′, and the perfusion fraction, f′, was performed by using a simplified IVIM approach. Parameters were analyzed voxel-wise. Tumor response was assessed in a central slice by using a region of interest (ROI) covering the whole tumor. HCCs were categorized into two groups, responders and nonresponders, according to tumor size changes on first and second follow ups (if available) and changes of contrast-enhanced region on the first follow up. RESULTS: In total, 31 HCCs were analyzed: 17 lesions were assigned to responders and 14 were to nonresponders. In responders, ADC(0,800) and D′ were increased after therapy by ~30% (P=0.00004) and ~42% (P=0.00001), respectively, whereas f′ was decreased by ~37% (P=0.00094). No significant changes were found in nonresponders. Responders and nonresponders were better differentiated by changes in D′ than by changes in ADC(0,800) (area under the curve =0.878 vs 0.819 or 0.714, respectively). CONCLUSION: In patients with HCCs undergoing embolization therapy, diffusion changes were better reflected by D′ than by conventional ADC(0,800), which is influenced by counteracting perfusion changes as assessed by f′. |
format | Online Article Text |
id | pubmed-5079699 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-50796992016-10-31 Intravoxel incoherent motion model–based analysis of diffusion-weighted magnetic resonance imaging with 3 b-values for response assessment in locoregional therapy of hepatocellular carcinoma Mürtz, Petra Penner, Arndt-Hendrik Pfeiffer, Anne-Kristina Sprinkart, Alois M Pieper, Claus C König, Roy Block, Wolfgang Schild, Hans H Willinek, Winfried A Kukuk, Guido M Onco Targets Ther Original Research PURPOSE: The aim of this study was to evaluate an intravoxel incoherent motion (IVIM) model–based analysis of diffusion-weighted imaging (DWI) for assessing the response of hepatocellular carcinoma (HCC) to locoregional therapy. PATIENTS AND METHODS: Respiratory-gated DWI (b=0, 50, and 800 s/mm(2)) was retrospectively analyzed in 25 patients who underwent magnetic resonance imaging at 1.5 T before and 6 weeks following the first cycle of transarterial chemoembolization therapy, transarterial ethanol-lipiodol embolization therapy, and transarterial radioembolization therapy. In addition to the determination of apparent diffusion coefficient, ADC(0,800), an estimation of the diffusion coefficient, D′, and the perfusion fraction, f′, was performed by using a simplified IVIM approach. Parameters were analyzed voxel-wise. Tumor response was assessed in a central slice by using a region of interest (ROI) covering the whole tumor. HCCs were categorized into two groups, responders and nonresponders, according to tumor size changes on first and second follow ups (if available) and changes of contrast-enhanced region on the first follow up. RESULTS: In total, 31 HCCs were analyzed: 17 lesions were assigned to responders and 14 were to nonresponders. In responders, ADC(0,800) and D′ were increased after therapy by ~30% (P=0.00004) and ~42% (P=0.00001), respectively, whereas f′ was decreased by ~37% (P=0.00094). No significant changes were found in nonresponders. Responders and nonresponders were better differentiated by changes in D′ than by changes in ADC(0,800) (area under the curve =0.878 vs 0.819 or 0.714, respectively). CONCLUSION: In patients with HCCs undergoing embolization therapy, diffusion changes were better reflected by D′ than by conventional ADC(0,800), which is influenced by counteracting perfusion changes as assessed by f′. Dove Medical Press 2016-10-19 /pmc/articles/PMC5079699/ /pubmed/27799790 http://dx.doi.org/10.2147/OTT.S113909 Text en © 2016 Mürtz et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Mürtz, Petra Penner, Arndt-Hendrik Pfeiffer, Anne-Kristina Sprinkart, Alois M Pieper, Claus C König, Roy Block, Wolfgang Schild, Hans H Willinek, Winfried A Kukuk, Guido M Intravoxel incoherent motion model–based analysis of diffusion-weighted magnetic resonance imaging with 3 b-values for response assessment in locoregional therapy of hepatocellular carcinoma |
title | Intravoxel incoherent motion model–based analysis of diffusion-weighted magnetic resonance imaging with 3 b-values for response assessment in locoregional therapy of hepatocellular carcinoma |
title_full | Intravoxel incoherent motion model–based analysis of diffusion-weighted magnetic resonance imaging with 3 b-values for response assessment in locoregional therapy of hepatocellular carcinoma |
title_fullStr | Intravoxel incoherent motion model–based analysis of diffusion-weighted magnetic resonance imaging with 3 b-values for response assessment in locoregional therapy of hepatocellular carcinoma |
title_full_unstemmed | Intravoxel incoherent motion model–based analysis of diffusion-weighted magnetic resonance imaging with 3 b-values for response assessment in locoregional therapy of hepatocellular carcinoma |
title_short | Intravoxel incoherent motion model–based analysis of diffusion-weighted magnetic resonance imaging with 3 b-values for response assessment in locoregional therapy of hepatocellular carcinoma |
title_sort | intravoxel incoherent motion model–based analysis of diffusion-weighted magnetic resonance imaging with 3 b-values for response assessment in locoregional therapy of hepatocellular carcinoma |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5079699/ https://www.ncbi.nlm.nih.gov/pubmed/27799790 http://dx.doi.org/10.2147/OTT.S113909 |
work_keys_str_mv | AT murtzpetra intravoxelincoherentmotionmodelbasedanalysisofdiffusionweightedmagneticresonanceimagingwith3bvaluesforresponseassessmentinlocoregionaltherapyofhepatocellularcarcinoma AT pennerarndthendrik intravoxelincoherentmotionmodelbasedanalysisofdiffusionweightedmagneticresonanceimagingwith3bvaluesforresponseassessmentinlocoregionaltherapyofhepatocellularcarcinoma AT pfeifferannekristina intravoxelincoherentmotionmodelbasedanalysisofdiffusionweightedmagneticresonanceimagingwith3bvaluesforresponseassessmentinlocoregionaltherapyofhepatocellularcarcinoma AT sprinkartaloism intravoxelincoherentmotionmodelbasedanalysisofdiffusionweightedmagneticresonanceimagingwith3bvaluesforresponseassessmentinlocoregionaltherapyofhepatocellularcarcinoma AT pieperclausc intravoxelincoherentmotionmodelbasedanalysisofdiffusionweightedmagneticresonanceimagingwith3bvaluesforresponseassessmentinlocoregionaltherapyofhepatocellularcarcinoma AT konigroy intravoxelincoherentmotionmodelbasedanalysisofdiffusionweightedmagneticresonanceimagingwith3bvaluesforresponseassessmentinlocoregionaltherapyofhepatocellularcarcinoma AT blockwolfgang intravoxelincoherentmotionmodelbasedanalysisofdiffusionweightedmagneticresonanceimagingwith3bvaluesforresponseassessmentinlocoregionaltherapyofhepatocellularcarcinoma AT schildhansh intravoxelincoherentmotionmodelbasedanalysisofdiffusionweightedmagneticresonanceimagingwith3bvaluesforresponseassessmentinlocoregionaltherapyofhepatocellularcarcinoma AT willinekwinfrieda intravoxelincoherentmotionmodelbasedanalysisofdiffusionweightedmagneticresonanceimagingwith3bvaluesforresponseassessmentinlocoregionaltherapyofhepatocellularcarcinoma AT kukukguidom intravoxelincoherentmotionmodelbasedanalysisofdiffusionweightedmagneticresonanceimagingwith3bvaluesforresponseassessmentinlocoregionaltherapyofhepatocellularcarcinoma |